This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ Finnish Probiotic {Valio Probiotic}

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Gastrointestinal Health: Lactobacillus rhamnosus GG is perhaps best known for its beneficial effects on gastrointestinal health. It helps maintain a healthy balance of gut microbiota by competing with harmful bacteria for resources and attachment sites in the intestines. LGG has been studied for its efficacy in preventing and managing various gastrointestinal conditions, including acute infectious diarrhea (such as rotavirus gastroenteritis), antibiotic-associated diarrhea, traveler's diarrhea, inflammatory bowel diseases (such as Crohn's disease and ulcerative colitis), and irritable bowel syndrome (IBS).

  2. Immune System Support: Lactobacillus rhamnosus GG has immunomodulatory properties, meaning it can regulate immune responses. It stimulates the production of certain immune cells and cytokines, which helps strengthen the body's immune defense against infections and reduce inflammation. LGG has been studied for its potential to prevent respiratory tract infections (such as the common cold and flu) and reduce the severity of allergic conditions (such as allergic rhinitis and atopic dermatitis).

  3. Women's Health: Lactobacillus rhamnosus GG may play a role in promoting vaginal health by maintaining a balanced vaginal microbiota and inhibiting the growth of pathogenic bacteria and yeast. It is commonly used in probiotic formulations intended to prevent and manage vaginal infections such as bacterial vaginosis and yeast infections. LGG-containing probiotics may also help prevent urinary tract infections (UTIs) in women by modulating the urogenital microbiota.

  4. Digestive Health: Lactobacillus rhamnosus GG has been studied for its ability to alleviate symptoms of lactose intolerance by aiding in the digestion of lactose. It produces lactase enzyme, which helps break down lactose into simpler sugars that are more easily absorbed by the body. LGG may also help improve symptoms of bloating, gas, and abdominal discomfort associated with lactose intolerance.

  5. Pediatric Health: Lactobacillus rhamnosus GG is safe for use in children and has been extensively studied in pediatric populations. It is commonly used to prevent and manage various pediatric gastrointestinal conditions, including acute infectious diarrhea, antibiotic-associated diarrhea, and infantile colic. LGG-containing probiotics may also help reduce the risk of developing allergies and eczema in infants when given prenatally and postnatally to pregnant women and breastfeeding mothers.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of Finnish Probiotic {Valio Probiotic} On Probiotics

Bacteria Impacted by Finnish Probiotic {Valio Probiotic}

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

Impact of Finnish Probiotic {Valio Probiotic} on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]